OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Help
Advanced
Search
4
Results
Show all
Save search
Copy query
Show results for
Unknown
(2)
Proteomics
(2)
Organisms
Alphavirus
(2)
Anemia
(2)
Betaherpesvirinae
(2)
Brassica oleracea var. oleracea
(2)
Cowpox virus
(2)
Coxsackievirus
(2)
Cytomegalovirus
(2)
Dengue virus
(2)
EFO:0001352
(2)
Filoviridae
(2)
Hepatitis B virus
(2)
Human alphaherpesvirus 1
(2)
Human betaherpesvirus 5
(2)
Human immunodeficiency virus
(2)
Human immunodeficiency virus 1
(2)
Human immunodeficiency virus 2
(2)
Influenza A virus
(2)
Influenza C virus
(2)
Japanese encephalitis virus group
(2)
Lyssavirus rabies
(2)
Monkeypox virus
(2)
Nostoc sp. PCC 7120 = FACHB-418
(2)
Oropouche virus
(2)
Orthopoxvirus
(2)
Orthopoxvirus vaccinia
(2)
Rattus
(2)
Staphylococcus aureus
(2)
Streptococcus pneumoniae
(2)
Viruses
(2)
West Nile virus
(2)
Repository
pride
(2)
Tissue
Melanocyte
(2)
Cell culture
(1)
Lymph node
(1)
Disease
Melanoma
(2)
Technology Type
Mass Spectrometry
(2)
Shotgun proteomics
(2)
Publication Date
2018
(1)
2014
(1)
Release Date
2017
(1)
2014
(1)
Lab affiliation
Dept. of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden; Clinical proteomics mass spectrometry, Science for Life Laboratory, Sweden.
(1)
Janne Lehtiö Science for Life Laboratory/Karolinska Institutet Cancer Proteomics Mass spectrometry Tomtebodavägen 23 171 76 Solna Sweden
(1)
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
Proteomics analysis of melanoma metastases: association between S100A13 expression and chemotherapy resistance.
Not available
S-EPMC4021518
|
biostudies-literature
Cite
Melanoma metastases: association between S100A13 expression and chemotherapy resistance
Here we have performed quantitative profiling of the proteome of lymph node metastasis from patients with melanoma with different response to chemotherapy.
ORGANISM(S):
Homo sapiens (Human)
2014-04-25
|
PXD000928
|
Pride
Lymph nodes
Isoelectric focusing
Melanoma
S100a13
Metastasis
Cite
Silencing FLI or targeting CD13/ANPEP lead to dephosphorylation of EPHA2, a mediator of BRAF inhibitor resistance, and induce growth arrest or apoptosis in melanoma cells.
Not available
S-EPMC5596587
|
biostudies-literature
Cite
BRAF inhibitor resistance in melanoma cell lines
LC-MS/MS analysis of cell lines with induced resistance to BRAF inhibitors
ORGANISM(S):
Homo sapiens (Human)
2018-10-19
|
PXD001682
|
Pride
Braf resistance
Melanoma
Cite
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets
